Eur Respir J 2001; 17:1228-1235
Copyright ©ERS Journals Ltd 2001
Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats
J. Cortijo1,
M. Cerdá-Nicolás2,
A. Serrano3,
G. Bioque3,
J.M. Estrela4,
F. Santangelo5,
A. Esteras6,
A. Llombart-Bosch2 and
E.J. Morcillo1
Depts of 1 Pharmacology, 2 Pathology and 4 Physiology, University of València, 3 Dept of Medical Bioanalysis, Instituto de Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigacions Cientificas, Barcelona, Spain, Zambon Group Spa, 5 Bresso, Italy and 6 , Barcelona, Spain
CORRESPONDENCE: J. Morcillo, Dept of Pharmacology, Faculty of Medicine, Av. Blasco Ibanez 15, E-46010, Valencia, Spain. Fax: 34 963864622
Keywords: bleomycin, inflammation, N-acetylcysteine, pulmonary fibrosis, rat
Received: June 5, 2000
Accepted January 25, 2001
The present work was supported by grant 1FD97-1143 from the European Union (Regional Development Funds; FEDER), CICYT (Spanish Government) and Regional Government (Generalitat Valenciana), and a research grant from Zambon Group (Milano, Italy and Barcelona, Spain).
Antioxidant therapy may be useful in diseases with impaired oxidant-antioxidant balance such as pulmonary fibrosis. This study examines the effect of N-acetylcysteine (NAC) on bleomycin-induced lung fibrosis in rats.
NAC (3 mmol·kg1; oral) was given daily from 1 week prior to a single intratracheal instillation of bleomycin (2.5 U·kg1) or saline, until 14 days postinstillation.
NAC partially decreased the augmented collagen deposition in bleomycin-exposed rats (hydroxyproline content was 4,354±386 and 3,416±326 µg·lung1 in vehicle-treated and NAC-treated rats, respectively; p<0.05). The histological assessment using a semiquantitative score showed less collagen deposition and inflammatory cells in NAC-treated rats compared to those receiving bleomycin alone. NAC failed to inhibit the bleomycin-induced increases in lung wet weight and in cell counts and protein levels of bronchoalveolar lavage fluid, but significantly increased total glutathione and taurine levels in bronchoalveolar lavage fluid.
These results indicate that oral N-acetylcysteine improves the pulmonary antioxidant protection and may be useful in reducing lung damage produced by bleomycin.
This article has been cited by other articles:

|
 |

|
 |
 
S. S. Iyer, A. M. Ramirez, J. D. Ritzenthaler, E. Torres-Gonzalez, S. Roser-Page, A. L. Mora, K. L. Brigham, D. P. Jones, J. Roman, and M. Rojas
Oxidation of extracellular cysteine/cystine redox state in bleomycin-induced lung fibrosis
Am J Physiol Lung Cell Mol Physiol,
January 1, 2009;
296(1):
L37 - L45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ishii, S. Fujimoto, and T. Fukuda
Gefitinib Prevents Bleomycin-induced Lung Fibrosis in Mice
Am. J. Respir. Crit. Care Med.,
September 1, 2006;
174(5):
550 - 556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Molina-Molina, A Serrano-Mollar, O Bulbena, L Fernandez-Zabalegui, D Closa, A Marin-Arguedas, A Torrego, J Mullol, C Picado, and A Xaubet
Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis
Thorax,
July 1, 2006;
61(7):
604 - 610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Barreiro, J. B. Galdiz, M. Marinan, F. J. Alvarez, S. N. A. Hussain, J. Gea, and on behalf of the ENIGMA in COPD project
Respiratory loading intensity and diaphragm oxidative stress: N-acetyl-cysteine effects
J Appl Physiol,
February 1, 2006;
100(2):
555 - 563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Barreiro, D. Sanchez, J. B. Galdiz, S. N. A. Hussain, J. Gea, and on behalf of the ENIGMA in COPD project
N-acetylcysteine increases manganese superoxide dismutase activity in septic rat diaphragms
Eur. Respir. J.,
December 1, 2005;
26(6):
1032 - 1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Rubio, M. C. Martin-Mosquero, M. Ortega, G. Peces-Barba, and N. Gonzalez-Mangado
Oral N-Acetylcysteine Attenuates Elastase-Induced Pulmonary Emphysema in Rats
Chest,
April 1, 2004;
125(4):
1500 - 1506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mata, A. Ruiz, M. Cerda, M. Martinez-Losa, J. Cortijo, F. Santangelo, A. Serrano-Mollar, A. Llombart-Bosch, and E.J. Morcillo
Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats
Eur. Respir. J.,
December 1, 2003;
22(6):
900 - 905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Koslowski, K. Knoch, E. Kuhlisch, D. Seidel, and M. Kasper
Cathepsins in bleomycin-induced lung injury in rat
Eur. Respir. J.,
September 1, 2003;
22(3):
427 - 435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Blesa, J. Cortijo, M. Mata, A. Serrano, D. Closa, F. Santangelo, J.M. Estrela, J. Suchankova, and E.J. Morcillo
Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen
Eur. Respir. J.,
March 1, 2003;
21(3):
394 - 400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Serrano-Mollar, D Closa, J Cortijo, E J Morcillo, N Prats, M Gironella, J Panes, J Rosello-Catafau, and O Bulbena
P-selectin upregulation in bleomycin induced lung injury in rats: effect of N-acetyl-L-cysteine
Thorax,
July 1, 2002;
57(7):
629 - 634.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the European Respiratory Society.
|